🇺🇸 FDA
Patent

US 11028061

Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof

granted A61KA61K31/426A61K31/428

Quick answer

US patent 11028061 (Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/426, A61K31/428, A61K31/4439, A61K31/454